Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2012 1
2013 3
2014 1
2015 3
2016 3
2017 1
2018 2
2019 2
2020 3
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.
Panuzzo C, Signorino E, Calabrese C, Ali MS, Petiti J, Bracco E, Cilloni D. Panuzzo C, et al. Among authors: signorino e. J Clin Med. 2020 Mar 16;9(3):802. doi: 10.3390/jcm9030802. J Clin Med. 2020. PMID: 32188030 Free PMC article. Review.
A novel assay to detect calreticulin mutations in myeloproliferative neoplasms.
Rosso V, Petiti J, Bracco E, Pedrola R, Carnuccio F, Signorino E, Carturan S, Calabrese C, Bot-Sartor G, Ronconi M, Serra A, Saglio G, Frassoni F, Cilloni D. Rosso V, et al. Among authors: signorino e. Oncotarget. 2017 Jan 24;8(4):6399-6405. doi: 10.18632/oncotarget.14113. Oncotarget. 2017. PMID: 28031530 Free PMC article.
Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1.
Lo Iacono M, Signorino E, Petiti J, Pradotto M, Calabrese C, Panuzzo C, Caciolli F, Pergolizzi B, De Gobbi M, Rege-Cambrin G, Fava C, Giachino C, Bracco E, Saglio G, Frassoni F, Cilloni D. Lo Iacono M, et al. Among authors: signorino e. Cancers (Basel). 2021 Jan 14;13(2):293. doi: 10.3390/cancers13020293. Cancers (Basel). 2021. PMID: 33466839 Free PMC article.
Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.
Cilloni D, Carturan S, Bracco E, Campia V, Rosso V, Torti D, Calabrese C, Gaidano V, Niparuck P, Favole A, Signorino E, Iacobucci I, Morano A, De Luca L, Musto P, Frassoni F, Saglio G. Cilloni D, et al. Among authors: signorino e. Leuk Res. 2013 May;37(5):520-30. doi: 10.1016/j.leukres.2013.01.014. Epub 2013 Feb 12. Leuk Res. 2013. PMID: 23415111 Clinical Trial.
22 results